Close
4

Promoted Content Promoted Content

X

Market Place

Market Place

Menu

Menu

Post Enquiry

Post Enquiry

PharmaCompass

Home

Market Place

Market Place

Search

    Find

    • Active Pharmaceutical Ingredients Active Pharmaceutical Ingredients
    • Finished Drug Formulations Finished Drug Formulations
    • Price Prices
    • Excipients Excipients
    • Services Services
    • Market Place Marketplace

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry

    Company profile for Clementia Pharmaceuticals

    Client Virtual Booth
    CLEMENTIA PHARMACEUTICALS

    CLEMENTIA PHARMACEUTICALS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    MEDIA

    ,

    PharmaCompass
    About the Company
    Contact SupplierContact Supplier
    #SpeakPharma
    #LearnMore
    We are developing palovarotene, an investigational retinoic acid receptor gamma (RARγ) selective agonist, for the treatment of individuals who are affected by fibrodysplasia ossificans progressiva (FOP), multiple osteochondromas (MO) and other diseases. For FOP, we are preparing for a New Drug Application (NDA) for episodic, flare-up based palovarotene treatment, which we intend to submit to the U.S. Food and Drug Administrat...
    We are developing palovarotene, an investigational retinoic acid receptor gamma (RARγ) selective agonist, for the treatment of individuals who are affected by fibrodysplasia ossificans progressiva (FOP), multiple osteochondromas (MO) and other diseases. For FOP, we are preparing for a New Drug Application (NDA) for episodic, flare-up based palovarotene treatment, which we intend to submit to the U.S. Food and Drug Administration (FDA) in the second half of 2019, and subject to approval, a U.S. commercial launch in the first half of 2020.We also completed enrollment in our Phase 3 MOVE Trial in FOP in August 2018.
    Upgrade the company profile

    Upgrade this company profile// Update & customize all content.
    Ask PharmaCompass, click HERE.

    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Clementia Pharmaceuticals
    Canada Flag
    Country
    Country
    CANADA
    Address
    Address
    1000 de la Gauchetière O, Suite 1200 Montreal, QC H3B 4W5
    Telephone
    Telephone
    +1 (514) 940-3600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://clementiapharma.com
    Linkedin
    Linkedin
    https://in.linkedin.com/company/clementia-pharmaceuticals-inc-
    Twitter
    Twitter
    https://twitter.com/clementiapharma?lang=en
    Client Virtual Booth

    Upgrade this company profile// Update & customize all content.
    Ask PharmaCompass, click HERE.

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    Learn More About
    wavelength-pharmaceuticals-m-2021-09-20

    Access Virtual Booth

    Contact Supplier

    Advertise With Us

    Send me more info on How To Grow My Business Digitally?

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search